Myomo (MYO) Return on Capital Employed (2017 - 2025)
Myomo (MYO) reported Return on Capital Employed of 43.7% for Q3 2025, up 4696.0% on a YoY basis from 0.91% in Q3 2024, and down 31.44% quarter-over-quarter from 33.24% in Q2 2025.
Myomo (MYO) Return on Capital Employed (2017 - 2025) Analysis & Trends
Myomo has reported Return on Capital Employed for 9 years, with the latest figure at 43.7% in Q3 2025.
- For the quarter ending Q3 2025, Return on Capital Employed rose 4696.0% year-over-year to 43.7%; the trailing twelve-month figure through Sep 2025 stood at 43.7% (up 4696.0% YoY), and the FY2024 full-year result was 34.03%, up 8536.0% from the prior year.
- Return on Capital Employed for Q3 2025 stood at 43.7%, down from 33.24% in the prior quarter.
- The five-year high for Return on Capital Employed was 19.54% in Q1 2025, with the low at 141.35% in Q4 2022.
- Historically, Return on Capital Employed has averaged 78.44% across 5 years, with a median of 79.6% in 2023.
- Annual changes were most pronounced in 2021 — Return on Capital Employed jumped 8885 bps — and 2022, when it slumped 7050 bps.
- Myomo's Return on Capital Employed stood at 70.84% in 2021, then sank by 100 bps to 141.35% in 2022, then surged by 44 bps to 79.6% in 2023, then soared by 59 bps to 32.48% in 2024, then tumbled by 35 bps to 43.7% in 2025.
- The last three Return on Capital Employed figures came in at 43.7% (Q3 2025), 33.24% (Q2 2025), and 19.54% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -43.70% |
| Jun 30, 2025 | -33.24% |
| Mar 31, 2025 | -19.54% |
| Dec 31, 2024 | -32.48% |
| Sep 30, 2024 | -90.65% |
| Jun 30, 2024 | -95.66% |
| Mar 31, 2024 | -94.54% |
| Dec 31, 2023 | -79.60% |
| Sep 30, 2023 | -85.42% |
| Jun 30, 2023 | -96.11% |
| Mar 31, 2023 | -132.44% |
| Dec 31, 2022 | -141.35% |
| Sep 30, 2022 | -120.69% |
| Jun 30, 2022 | -83.74% |
| Mar 31, 2022 | -70.04% |
| Dec 31, 2021 | -70.84% |
| Sep 30, 2021 | -66.72% |
| Jun 30, 2021 | -60.66% |
| Mar 31, 2021 | -72.98% |
| Dec 31, 2020 | -86.35% |